Echo(1) | $15,000,000 | (Aug 1, 2025)
KredosAi | Undisclosed Amount | (Aug 1, 2025)
Cline | $32,000,000 | (Aug 1, 2025)
Certified by Founder
Lodge
Pathalys Pharma
start up
United States
- Raleigh, North Carolina
- 07/02/2023
- Unknown
- $150,000,000
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
- Industry Biotechnology Research
- Website https://pathalys.com/
- LinkedIn https://www.linkedin.com/company/pathalys/
Moonshine AI | Undisclosed Amount | (Aug 1, 2025)
Noma Security | $100,000,000 | (Aug 1, 2025)
Anaconda, Inc. | $150,000,000 | (Aug 1, 2025)
Nebulock | $8,500,000 | (Aug 1, 2025)
MyPrize | $21,000,000 | (Aug 1, 2025)
Safe Security | $70,000,000 | (Aug 1, 2025)
Merso | $3,000,000 | (Aug 1, 2025)
Metaforms | $9,000,000 | (Aug 1, 2025)
Ultromics | $55,000,000 | (Jul 31, 2025)